Pages that link to "Q38282541"
Jump to navigation
Jump to search
The following pages link to Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype. (Q38282541):
Displaying 17 items.
- The urgent need to recover MHC class I in cancers for effective immunotherapy (Q26770165) (← links)
- Identification of the core regulators of the HLA I-peptide binding process (Q29048598) (← links)
- Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells. (Q37687254) (← links)
- Rejection versus escape: the tumor MHC dilemma (Q39063943) (← links)
- The controversial role of TNF in melanoma (Q40437125) (← links)
- Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer (Q42056165) (← links)
- Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. (Q42511974) (← links)
- MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy. (Q50054492) (← links)
- MUC1 immunotherapy against a metastatic mammary adenocarcinoma model: Importance of IFN-gamma. (Q51626800) (← links)
- Dysfunction of antigen processing and presentation by dendritic cells in cancer (Q88301302) (← links)
- Cancer immune escape: MHC expression in primary tumours versus metastases (Q90060380) (← links)
- Improving the Clinical Application of Natural Killer Cells by Modulating Signals Signal from Target Cells (Q91928175) (← links)
- Mutations in the ND2 Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells (Q92082570) (← links)
- MHC/HLA Class I Loss in Cancer Cells (Q92364680) (← links)
- Immunity in cancer and atherosclerosis (Q92798580) (← links)
- Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor (Q96306487) (← links)
- The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing (Q103803294) (← links)